Literature DB >> 25530382

Prevalence of prostatic calcification subtypes and association with prostate cancer.

Michal Smolski1, Rafal Turo2, Sigrid Whiteside3, Stephen Bromage2, Gerald N Collins2.   

Abstract

OBJECTIVE: To evaluate the prevalence and to classify prostatic calcification on transrectal ultrasonography (TRUS) and correlate the findings with histology.
METHODS: A prospective, blinded study of men undergoing TRUS and prostatic biopsy was designed. A standardized reproducible technique was used with a BK 7.5- to 12.5-MHz multiplanar probe. Representative images of the calcification in the sagittal and transverse planes were captured. Blind analysis by an experienced observer was performed. TRUS findings were categorized using a novel classification and correlated with histologic data.
RESULTS: A total of 274 patients (58.8%) had prostate cancer, 88 patients (18.9%) inflammation, and 104 patients (22.3%) had benign pathology. Interface calcification was present in 42.3% of patients. Peripheral or transitional zone calcification was unusual (6.8% and 9.0%, respectively). Of the peripheral zone calcification group patients, 78.1% had cancer on histology examination (P = .020).
CONCLUSION: Prevalence and characteristics of prostatic calcification have been described using this novel and practical classification. Although interface calcification is common and not associated with any particular pathology, peripheral zone calcification appears to be strongly associated with prostate cancer.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25530382     DOI: 10.1016/j.urology.2014.09.026

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

Review 1.  Fiducial marker guided prostate radiotherapy: a review.

Authors:  Angela G M O'Neill; Suneil Jain; Alan R Hounsell; Joe M O'Sullivan
Journal:  Br J Radiol       Date:  2016-09-23       Impact factor: 3.039

2.  Ultrasound detection of prostatic calculi as a parameter to predict the appearance of hematospermia after a prostate biopsy.

Authors:  Lucio Dell'Atti
Journal:  Int Braz J Urol       Date:  2017 Nov-Dec       Impact factor: 1.541

3.  SpidermiR: An R/Bioconductor Package for Integrative Analysis with miRNA Data.

Authors:  Claudia Cava; Antonio Colaprico; Gloria Bertoli; Alex Graudenzi; Tiago C Silva; Catharina Olsen; Houtan Noushmehr; Gianluca Bontempi; Giancarlo Mauri; Isabella Castiglioni
Journal:  Int J Mol Sci       Date:  2017-01-27       Impact factor: 5.923

4.  The prevalence and risk factors of prostatic calcification: an analysis of 68 705 subjects.

Authors:  Zhuang Tang; Xiao-Mei Wu; Qiang Wei; Lin-Na Wu
Journal:  Asian J Androl       Date:  2018 Jul-Aug       Impact factor: 3.285

Review 5.  Pathological Mineralization: The Potential of Mineralomics.

Authors:  Elena Tsolaki; Sergio Bertazzo
Journal:  Materials (Basel)       Date:  2019-09-25       Impact factor: 3.623

6.  Observed high incidence of prostatic calculi with the potential to act as natural fiducials for prostate image guided radiotherapy.

Authors:  A G M O'Neill; S O Osman; S Jain; A R Hounsell; J M O'Sullivan
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2019-03-12

7.  Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients.

Authors:  Brendan A Daisley; Ryan M Chanyi; Kamilah Abdur-Rashid; Kait F Al; Shaeley Gibbons; John A Chmiel; Hannah Wilcox; Gregor Reid; Amanda Anderson; Malcolm Dewar; Shiva M Nair; Joseph Chin; Jeremy P Burton
Journal:  Nat Commun       Date:  2020-09-24       Impact factor: 14.919

8.  Prostatic calcifications: Quantifying occurrence, radiodensity, and spatial distribution in prostate cancer patients.

Authors:  Saurabh Singh; Eleanor Martin; Henry F J Tregidgo; Bradley Treeby; Steve Bandula
Journal:  Urol Oncol       Date:  2021-01-20       Impact factor: 3.498

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.